BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28260023)

  • 1. Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.
    Griffith J; Andrade D; Mehta M; Berry W; Benbrook DM; Aravindan N; Herman TS; Ramesh R; Munshi A
    Oncol Rep; 2017 Apr; 37(4):2382-2390. PubMed ID: 28260023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
    M JR; S V
    Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy.
    Mehta M; Basalingappa K; Griffith JN; Andrade D; Babu A; Amreddy N; Muralidharan R; Gorospe M; Herman T; Ding WQ; Ramesh R; Munshi A
    Oncotarget; 2016 Oct; 7(40):64820-64835. PubMed ID: 27588488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer.
    Jang NY; Kim DH; Cho BJ; Choi EJ; Lee JS; Wu HG; Chie EK; Kim IA
    BMC Cancer; 2015 Mar; 15():89. PubMed ID: 25884663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. siRNA-mediated suppression of collagen type iv alpha 2 (COL4A2) mRNA inhibits triple-negative breast cancer cell proliferation and migration.
    JingSong H; Hong G; Yang J; Duo Z; Li F; WeiCai C; XueYing L; YouSheng M; YiWen O; Yue P; Zou C
    Oncotarget; 2017 Jan; 8(2):2585-2593. PubMed ID: 27906681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells.
    Mourgues L; Imbert V; Nebout M; Colosetti P; Neffati Z; Lagadec P; Verhoeyen E; Peng C; Duprez E; Legros L; Rochet N; Maguer-Satta V; Nicolini FE; Mary D; Peyron JF
    Leukemia; 2015 Oct; 29(10):1993-2002. PubMed ID: 25925206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bmi1 gene silencing inhibits the proliferation and invasiveness of human hepatocellular carcinoma cells and increases their sensitivity to 5-fluorouracil.
    Zhang R; Xu LB; Yue XJ; Yu XH; Wang J; Liu C
    Oncol Rep; 2013 Mar; 29(3):967-74. PubMed ID: 23242307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.
    Srinivasan M; Bharali DJ; Sudha T; Khedr M; Guest I; Sell S; Glinsky GV; Mousa SA
    Oncotarget; 2017 Jun; 8(24):38731-38742. PubMed ID: 28418883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1.
    Lin LC; Lee HT; Chien PJ; Huang YH; Chang MY; Lee YC; Chang WW
    Int J Med Sci; 2020; 17(14):2214-2224. PubMed ID: 32922184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells.
    Michmerhuizen AR; Chandler B; Olsen E; Wilder-Romans K; Moubadder L; Liu M; Pesch AM; Zhang A; Ritter C; Ward ST; Santola A; Nyati S; Rae JM; Hayes D; Feng FY; Spratt D; Wahl D; Eisner J; Pierce LJ; Speers C
    Front Endocrinol (Lausanne); 2020; 11():35. PubMed ID: 32117061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.
    Gergely JE; Dorsey AE; Dimri GP; Dimri M
    Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMI1 activates WNT signaling in colon cancer by negatively regulating the WNT antagonist IDAX.
    Yu F; Zhou C; Zeng H; Liu Y; Li S
    Biochem Biophys Res Commun; 2018 Feb; 496(2):468-474. PubMed ID: 29337063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Chk1 inhibitor MK-8776 increases the radiosensitivity of human triple-negative breast cancer by inhibiting autophagy.
    Zhou ZR; Yang ZZ; Wang SJ; Zhang L; Luo JR; Feng Y; Yu XL; Chen XX; Guo XM
    Acta Pharmacol Sin; 2017 Apr; 38(4):513-523. PubMed ID: 28042876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
    Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
    Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
    Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
    Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-15a/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1.
    Patel N; Garikapati KR; Ramaiah MJ; Polavarapu KK; Bhadra U; Bhadra MP
    Life Sci; 2016 Nov; 164():60-70. PubMed ID: 27596816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of Bmi-1 gene enhances chemotherapy sensitivity in human glioblastoma cells.
    Hong Y; Shang C; Xue YX; Liu YH
    Med Sci Monit; 2015 Apr; 21():1002-7. PubMed ID: 25858624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells.
    Wen Y; Dai G; Wang L; Fu K; Zuo S
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30842344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMI1 promotes the proliferation and inhibits autophagy of breast cancer cells by activating COPZ1.
    Chen S; Li H; Chen S; Wang B; Zhang K
    Clin Transl Oncol; 2022 Nov; 24(11):2166-2174. PubMed ID: 35789980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral vector-mediated doxycycline-inducible USP39 shRNA or cDNA expression in triple-negative breast cancer cells.
    Liu S; Liu X; Wang H; Zhou Q; Liang Y; Sui A; Yao R; Zhao B; Sun M
    Oncol Rep; 2015 May; 33(5):2477-83. PubMed ID: 25812575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.